US 10,759,779 J1 (287th)
	Crystalline form of orexin receptor antagonist, processes for preparation thereof and use thereof
Minhua Chen; Xiaoyu Zhang; Yanfeng Zhang; and Chunxiang Huang
Assigned to BERGEN PHARMACEUTICAL LLC
Trial No. PGR2021-00047, Feb. 3, 2021
Post-Grant Review Certificate for Patent 10,759,779, issued Sep. 1, 2020, Appl. No. 16/777,121, Jan. 30, 2020
Post-Grant Review Certificate issued Jan. 31, 2025